IMAZIO, Massimo
 Distribuzione geografica
Continente #
AS - Asia 2.143
NA - Nord America 1.578
EU - Europa 693
SA - Sud America 490
AF - Africa 57
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.968
Nazione #
US - Stati Uniti d'America 1.525
SG - Singapore 1.065
CN - Cina 406
BR - Brasile 381
VN - Vietnam 216
IT - Italia 208
HK - Hong Kong 164
FR - Francia 107
DE - Germania 106
IN - India 89
RU - Federazione Russa 69
AR - Argentina 45
KR - Corea 45
NL - Olanda 40
FI - Finlandia 32
GB - Regno Unito 26
AT - Austria 25
JP - Giappone 25
EC - Ecuador 24
ID - Indonesia 22
CA - Canada 20
MX - Messico 20
IE - Irlanda 18
BD - Bangladesh 15
ES - Italia 14
ZA - Sudafrica 14
TR - Turchia 13
PL - Polonia 11
PY - Paraguay 11
SE - Svezia 11
IQ - Iraq 10
KE - Kenya 10
PK - Pakistan 10
SA - Arabia Saudita 10
CL - Cile 9
IL - Israele 7
MA - Marocco 7
UZ - Uzbekistan 7
CO - Colombia 6
DO - Repubblica Dominicana 6
GR - Grecia 5
AU - Australia 4
CH - Svizzera 4
DZ - Algeria 4
JO - Giordania 4
MY - Malesia 4
PH - Filippine 4
TG - Togo 4
UA - Ucraina 4
UY - Uruguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
KZ - Kazakistan 3
LT - Lituania 3
PE - Perù 3
SN - Senegal 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DM - Dominica 2
JM - Giamaica 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
BH - Bahrain 1
BW - Botswana 1
CM - Camerun 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MG - Madagascar 1
MT - Malta 1
MW - Malawi 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
RW - Ruanda 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 4.968
Città #
Singapore 503
San Jose 309
Council Bluffs 224
Ashburn 201
Hong Kong 161
Beijing 115
Ho Chi Minh City 87
Lauterbourg 64
Los Angeles 64
Dallas 62
Mumbai 52
Pittsburgh 48
Hanoi 47
Hefei 47
Seoul 45
New York 37
Redondo Beach 31
Milan 30
Boardman 29
Buffalo 29
Frankfurt am Main 29
São Paulo 29
Munich 24
Santa Clara 24
Helsinki 23
Roubaix 22
Tokyo 21
Amsterdam 20
Vienna 18
Chicago 17
Dublin 17
Rio de Janeiro 17
Nuremberg 15
Atlanta 14
Orem 13
Rome 12
Turin 12
Chennai 11
The Dalles 11
Chandler 10
Düsseldorf 10
Stockholm 10
Curitiba 9
Da Nang 9
Guayaquil 9
Haiphong 9
North Bergen 9
Trieste 9
Udine 9
Baoding 8
Bologna 8
Johannesburg 8
Shenzhen 8
Suzhou 8
Changsha 7
Manchester 7
Mexico City 7
Montreal 7
Quito 7
Seattle 7
Xi'an 7
Brasília 6
Brooklyn 6
Buenos Aires 6
Denver 6
Houston 6
Nairobi 6
Phoenix 6
Porto Alegre 6
Thái Bình 6
Toronto 6
Warsaw 6
Ankara 5
Athens 5
Bari 5
Chengdu 5
Contagem 5
Fort Wayne 5
Fortaleza 5
Guarulhos 5
Hyderabad 5
Hải Dương 5
Mauá 5
Naples 5
Ogden 5
Riyadh 5
St Petersburg 5
Tashkent 5
Amman 4
Baghdad 4
Biên Hòa 4
Boston 4
Charlotte 4
Dhaka 4
Jacksonville 4
Lappeenranta 4
Lomé 4
Montevideo 4
Muggia 4
Nova Friburgo 4
Totale 2.910
Nome #
INFLA-score: A new diagnostic paradigm to identify pericarditis 123
Aortic pseudoaneurysm with a fistula between the non-coronary sinus and right atrium: a case report 105
Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging 96
Diagnosis, Risk Stratification, and Treatment of Pericarditis: A Review 96
[ANMCO Position paper: Care pathway for advanced heart failure patients candidate for heart transplantation/ventricular assist device] 95
Eosinophilic myocarditis: comprehensive update on pathophysiology, diagnosis, prognosis and management 95
Machine-learning tool for classifying pulmonary hypertension via expert reader-provided CT features: An educational resource for non-dedicated radiologists 91
Colchicine for the treatment of the spectrum of cardiovascular diseases: Current evidence and ongoing perspectives 87
Colchicine in acute coronary syndromes: the present and the possible future 87
New Developments in the Management of Recurrent Pericarditis 86
Leflunomide-induced pulmonary arterial hypertension: Case report and review of literature 86
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 86
Asymptomatic Chronic Large Pericardial Effusions: To Drain or to Observe? 85
Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis 82
Age-stratified patterns in clinical presentation, treatment and outcomes in acute pericarditis: a retrospective cohort study 81
ANMCO Position paper: Colchicine as a therapeutic agent in coronary syndromes 74
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 74
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept 73
Distal Reoperations after Repair of Acute Type A Aortic Dissection—Incidence, Causes and Outcomes 72
The 2023 new European guidelines on infective endocarditis: Main novelties and implications for clinical practice 70
Autoptic prevalence of pericarditis in coronavirus disease 2019 patients 69
The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases 68
Duration of Disease and Long-Term Outcomes in Patients With Difficult-To-Treat Recurrent Pericarditis: A Chronic Condition Treated With Nonsteroidal Anti-Inflammatory Drugs, Colchicine, Corticosteroids, and Anti–Interleukin-1 Agents 68
Critical approach to the 2023 European Society of Cardiology guidelines on cardiomyopathies: a document by the Working Group on Myocardial and Pericardial Diseases of the Italian Society of Cardiology 67
Management of cardiac sarcoidosis. A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC 66
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases 65
Anakinra-Dependent Recurrent Pericarditis: The Role of the R202Q Variant of the MEFV Gene 64
Recurrent pericarditis in older adults: Clinical and laboratory features and outcome 62
Pregnancy in patients with inherited myocardial disorders – A consensus document on preconception counseling and pregnancy management by the working group on myocardial and pericardial disorders of the Italian Society of Cardiology 62
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 62
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases 61
COVID-19 vaccines do not raise myocarditis and pericarditis incidence: Italian Society of Cardiology registry 61
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 61
Outcomes of acute pericarditis with an inflammatory phenotype 60
Post-cardiac injury syndrome and pericardial effusion recurrence after pericardial effusion drainage in chronic idiopathic pericardial effusion 60
Advancing our understanding of cardiac tumors 59
How to Use Interleukin-1 Antagonists in Patients With Pericarditis 58
Arrhythmic risk in acute myocarditis: Early threats, late events, and clinical uncertainty 55
Focus on 2023 ESC guidelines for the management of infective endocarditis: In light of new evidence 55
Should we start using colchicine for secondary prevention of acute and chronic coronary syndromes after 2024 European society of cardiology guidelines? 54
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 54
Unveiling the Spectrum of Pericardial Diseases: Insights, Novelties, and Future Directions 52
Inflammasome and ventricular arrhythmogenesis: Pathogenic interplay and potential targets on the horizon 51
Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension 51
Comparative Efficacy and Safety of Colchicine and Anti–Interleukin- 1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta- Analysis of Randomized Controlled Trials 51
Sudden cardiac death after acute myocarditis with arrhythmic presentation: Hunting for risk predictors - A systematic review and meta-analysis 51
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases 51
Risk Stratification of Recurrent Pericarditis: Hype or Hope? 50
Management of nonischemic-dilated cardiomyopathies in clinical practice: a position paper of the working group on myocardial and pericardial diseases of Italian Society of Cardiology 50
Colchicine for prevention of major adverse cardiovascular events: A meta-analysis of randomized clinical trials 49
Beyond the storm: rethinking recovery in fulminant myocarditis 49
When heart team really counts: Radical excision of intracardiac leiomyomatosis 49
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade 47
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 47
Prevention of pericardial complications after cardiac surgery: Myth or reality? 47
Medical therapy of pericarditis: Tips and tricks for clinical practice 45
One stage extraction and reimplantation of ICD/PM in patients with CIED related endocarditis and spondiloscitis due to E. faecalis treated with double beta-lactam combination: ampicillin plus ceftobiprole 43
Risk of incident pericarditis after coronavirus disease 2019 recovery: a systematic review and meta-analysis 43
Pericardial constrictive syndromes: a neglected cause of reversible heart failure 42
Scores for Risk Stratification of Pericarditis 39
Myocarditis: an increasing global health challenge! 35
Prognostic role of genetic variants in recurrent pericarditis 35
Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion 32
On the Road to Disclose the Pathogenesis of Pericarditis 31
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: A report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of Cardiology 29
Catheter ablation to prevent malignant ventricular arrhythmias in symptomatic Brugada syndrome: A systematic review and meta-analysis 29
Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases 23
Pericarditis at the crossroads: Unlocking the next wave of therapies 23
Inflammatory cardiomyopathy: an update for clinicians 19
Efficacy and safety of colchicine for the treatment of myopericarditis 19
The 2025 ESC myocarditis and pericarditis guidelines - what clinicians needs to know 18
Change in prevalence of ATTR variants in Italy: Results from a national survey 18
Comparative analysis of recurrence rates following various cessation strategies for rilonacept in recurrent pericarditis 17
Myocarditis and pericarditis in focus: A critical appraisal of the 2025 ESC vs ACC position statements from the Italian society of cardiology working group on cardiomyopathies and pericardial diseases 17
Management of myopericarditis 16
The top ten novelties of the ESC guidelines for the management of myocarditis and pericarditis 16
Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: A case series 15
Myocarditis and pericarditis exercise recommendations: a critical review of 2023 COCIS recommendations 15
Drug-induced pericarditis: a systematic review of all published cases 15
Myopericardial Diseases 14
Colchicine for acute and chronic coronary syndromes 14
CHAPTER 66: PERICARDIAL DISEASES 14
Editorial commentary: Pericardiocentesis: No more a subspecialty technique! 14
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry 13
Value of pericardial effusion as imaging biomarker in acute pericarditis, do we need to focus on more appropriate ones? 13
European Guidelines on Pericardial Diseases: a Focused Review of Novel Aspects 13
Triage and management of acute pericarditis 12
Trends in Acute Pericarditis Hospitalizations and Outcomes among the Elderly in the United States, 1999 - 2012 12
Transthoracic echocardiography for arrhythmic mitral valve prolapse: Phenotypic characterization as first step 12
Myocarditis and Pericarditis in Focus: A Brief Report Comparing the 2025 ESC Guidelines and Latest ACC Position Papers 11
The Torino Pericarditis Score: a new-risk stratification tool to predict complicated pericarditis 11
From Goliath to David: Interventricular fibroma 10
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al 10
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: When real-life scenarios face the shadows of the evidence-based medicine 10
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 10
Tolicizumab: a new option for refractory idiopathic recurrent pericarditis: a case report 10
Inflammation and genetics in myo-pericardial diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial Diseases 10
Anti-interleukin-1 agents for pericarditis: a primer for cardiologists 9
Pericardiocentesis With Extended Drainage and Colchicine: New Indication for Malignant Pericardial Effusions? 9
Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper 9
Totale 4.604
Categoria #
all - tutte 19.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 0 0 1 1
2022/202345 1 0 0 9 7 10 0 3 2 1 9 3
2023/2024134 2 2 33 15 8 7 1 13 7 11 19 16
2024/20251.262 35 67 52 87 67 55 66 73 186 102 219 253
2025/20264.705 244 364 472 447 400 249 254 149 981 1.145 0 0
Totale 6.155